Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients

NCT03618602 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Multiple Myeloma
Recurrent Multiple Myeloma

Interventions

DRUG: Bisthianostat

Sponsor

Shanghai Theorion Pharmaceutical Co Ltd.

Collaborators

[object Object]